Design Therapeutics (DSGN) News Today → READ THIS – If You Missed Out On The AI Boom (From Banyan Hill Publishing) (Ad) Free DSGN Stock Alerts $4.63 -0.14 (-2.94%) (As of 11:51 AM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineHold Rating Maintained for Design Therapeutics Amid Strategic Updates and Financial Reviewmarkets.businessinsider.com - May 10 at 9:12 AMDesign Therapeutics, Inc. (NASDAQ:DSGN) Receives Consensus Recommendation of "Hold" from Analystsamericanbankingnews.com - May 9 at 3:28 AMDSGN Stock Earnings: Design Therapeutics Beats EPS for Q1 2024msn.com - May 9 at 12:06 AMDesign Therapeutics Announces First Quarter 2024 Financial Results and Highlights Upcoming Program Milestonesglobenewswire.com - May 8 at 4:05 PMDesign Therapeutics (NASDAQ:DSGN) Upgraded to Overweight at Piper Sandleramericanbankingnews.com - May 8 at 5:52 AMPiper Sandler Upgrades Design Therapeutics (DSGN)msn.com - May 7 at 10:15 PMDesign Therapeutics climbs as Piper Sandler upgrades on pipelinemsn.com - May 7 at 5:15 PMBuy Rating Justified by Design Therapeutics’ Innovative Pipeline and Solid Financialsmarkets.businessinsider.com - May 7 at 12:14 PMPiper Sandler Upgrades Design Therapeutics (NASDAQ:DSGN) to "Overweight"marketbeat.com - May 7 at 7:30 AMDesign Therapeutics to Participate in the 2024 RBC Capital Markets Global Healthcare Conferenceglobenewswire.com - May 7 at 6:30 AMShort Interest in Design Therapeutics, Inc. (NASDAQ:DSGN) Rises By 7.2%americanbankingnews.com - May 2 at 3:42 AMDesign Therapeutics, Inc. (NASDAQ:DSGN) Sees Significant Growth in Short Interestmarketbeat.com - May 1 at 10:51 PM1,029,478 Shares in Design Therapeutics, Inc. (NASDAQ:DSGN) Acquired by BML Capital Management LLCmarketbeat.com - April 24 at 5:18 AMDesign Therapeutics, Inc. (NASDAQ:DSGN) Short Interest Updatemarketbeat.com - March 31 at 12:40 AMIndependent Director of Design Therapeutics Picks Up 88% More Stockfinance.yahoo.com - March 27 at 10:27 AMDesign Therapeutics And 2 Other Stocks Under $5 Insiders Are Buyingmsn.com - March 26 at 10:53 AMDesign Therapeutics, Inc. (NASDAQ:DSGN) Director John P. Schmid Purchases 9,156 Sharesinsidertrades.com - March 26 at 5:34 AMDesign Therapeutics, Inc. (NASDAQ:DSGN) Director Purchases $66,605.66 in Stockinsidertrades.com - March 26 at 4:44 AMJohn P. Schmid Acquires 9,156 Shares of Design Therapeutics, Inc. (NASDAQ:DSGN) Stockmarketbeat.com - March 25 at 9:33 PMDesign Therapeutics, Inc. to Post FY2026 Earnings of ($1.27) Per Share, Wedbush Forecasts (NASDAQ:DSGN)marketbeat.com - March 22 at 8:39 AMRBC Capital Reaffirms Their Hold Rating on Design Therapeutics (DSGN)markets.businessinsider.com - March 21 at 6:29 PMHold Rating Maintained for Design Therapeutics Amid Drug Reformulation and Program Updatesmarkets.businessinsider.com - March 21 at 6:29 PMLeerink Partnrs Comments on Design Therapeutics, Inc.'s FY2025 Earnings (NASDAQ:DSGN)marketbeat.com - March 21 at 8:36 AMDesign Therapeutics Outlines Progress Across GeneTAC(TM) Platform and Announces Fourth Quarter and Full Year 2023 Financial Resultsstockhouse.com - March 20 at 10:41 PMDesign Therapeutics (NASDAQ:DSGN) Receives Sector Perform Rating from Royal Bank of Canadamarketbeat.com - March 20 at 11:20 AMDesign Therapeutics, Inc. (NASDAQ:DSGN) Receives Consensus Rating of "Hold" from Brokeragesmarketbeat.com - March 20 at 11:19 AMDSGN Stock Earnings: Design Therapeutics Beats EPS for Q4 2023investorplace.com - March 19 at 10:01 PMDesign Therapeutics Inc (DSGN) Reports Full Year 2023 Financial Results and Pipeline Progressfinance.yahoo.com - March 19 at 7:35 PMDesign Therapeutics Outlines Progress Across GeneTAC™ Platform and Announces Fourth Quarter and Full Year 2023 Financial Resultsglobenewswire.com - March 19 at 4:01 PMDesign Therapeutics Inc (DSGN)investing.com - March 18 at 6:32 PMEarnings Preview For Design Therapeuticsbenzinga.com - March 18 at 1:28 PMDSGN Apr 2024 7.500 putfinance.yahoo.com - March 15 at 9:33 PMDSGN Jul 2024 2.500 putfinance.yahoo.com - March 15 at 9:33 PMDesign Therapeutics to Webcast Fourth Quarter and Full Year 2023 Financial Results and Comprehensive Portfolio Updateglobenewswire.com - March 12 at 6:30 AMDesign Therapeutics (DSGN) Set to Announce Earnings on Tuesdaymarketbeat.com - March 11 at 7:39 AMRTW Investments LP Boosts Stock Position in Design Therapeutics, Inc. (NASDAQ:DSGN)marketbeat.com - March 6 at 11:01 AMSR ONE CAPITAL PARTNERS I, LP's Net Worthbenzinga.com - February 9 at 4:07 PMDesign Therapeutics, Inc. (NASDAQ:DSGN) Receives Average Recommendation of "Hold" from Analystsmarketbeat.com - February 7 at 2:30 AMShort Interest in Design Therapeutics, Inc. (NASDAQ:DSGN) Grows By 9.7%marketbeat.com - January 15 at 7:36 AMDesign Therapeutics, Inc. (NASDAQ:DSGN) Given Average Rating of "Hold" by Analystsmarketbeat.com - January 13 at 2:22 AMShort Interest in Design Therapeutics, Inc. (NASDAQ:DSGN) Declines By 19.2%marketbeat.com - January 1 at 12:20 AMDesign Therapeutics, Inc. (NASDAQ:DSGN) Given Average Recommendation of "Hold" by Analystsmarketbeat.com - December 19 at 2:43 AMDesign Therapeutics, Inc. (DSGN) Upgraded to Buy: Here's What You Should Knowfinance.yahoo.com - December 18 at 2:25 PMDesign Therapeutics Inc DSGNmorningstar.com - December 7 at 10:52 PMPositive Signs As Multiple Insiders Buy Design Therapeutics Stockfinance.yahoo.com - November 25 at 9:18 AMHold Rating on Design Therapeutics Amid Mixed Efficacy Data, Strategic Realignment and Financial Uncertaintiesmarkets.businessinsider.com - November 16 at 11:57 PMDesign Therapeutics Inc (DSGN) Reports Q3 2023 Financials, Plans Strategic Updatefinance.yahoo.com - November 14 at 9:46 PMDesign Therapeutics Reports Third Quarter 2023 Financial Results and Plans for a Comprehensive Portfolio Update in Early 2024finance.yahoo.com - November 13 at 8:23 PMShort Interest in Design Therapeutics, Inc. (NASDAQ:DSGN) Drops By 42.2%marketbeat.com - September 15 at 8:26 AMAvoro Capital Advisors LLC Raises Stock Position in Design Therapeutics, Inc. (NASDAQ:DSGN)marketbeat.com - September 12 at 5:49 AM Get Design Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for DSGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Do This Today BEFORE Biden Wins in November (Ad)Discover "U.S.'s New Money" Before Biden Wins A new form of money has emerged in America, and it's making some folks wildly rich… (Musk and Bezos both use it). Find out how you can too in this free video. DSGN Media Mentions By Week DSGN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DSGN News Sentiment▼0.640.45▲Average Medical News Sentiment DSGN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DSGN Articles This Week▼121▲DSGN Articles Average Week Get Design Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for DSGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ZVRA News VERU News GTHX News ELYM News TELO News TRVI News LFCR News ALIM News ACRV News PRLD News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:DSGN) was last updated on 5/10/2024 by MarketBeat.com Staff From Our Partners[Webinar] A Deep Dive into Options Volatility: Skew & Relative ValueOICThis 1 Biotech Stock has been shocking the marketsHuge AlertsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaYou need to know these two things about AI stocks ASAP…InvestorPlaceShocking: One AI startup's revenue could surge 4,735%Manward PressHe Is Giving Away BitcoinCrypto Swap ProfitsCharles Payne Demystifies OptionsUnstoppable Prosperity[URGENT] DO NOT Touch These AI Stocks!Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Design Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
